Related Experiment Video
Updated: Aug 9, 2026

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells
Published on: February 21, 2018
PDGF-C is an EWS/FLI induced transforming growth factor in Ewing family tumors
1Department of Biochemistry and Molecular Genetics, University of Alabama at Birmingham, Birmingham, AL, USA.
Abstract:
The aberrant transcription factors associated with many human malignancies function by deregulation of tumorigenic pathways. However, identification of these pathways has come slowly. Virtually all cases of Ewing's Sarcoma and peripheral Primitive Neuroectodermal Tumor (PNET) are associated with aberrant transcription factors which fuse amino-terminal EWS with the DNA binding moiety of an ETS transcription factor (FLI-1 in 90% of cases). Attempts to identify the downstream targets of these chimeras in the Ewing Family Tumors (EFT) on the basis of differential gene regulation have produced little association with tumor biology. As an alternative approach, we have used highly efficient retroviral systems to biologically screen cDNA derived from cells transformed by EWS/FLI-1. We have identified the recently described PDGF-C as target of EWS/ETS transcriptional deregulation. This transcriptional deregulation is specific to EWS/FLI. PDGF-C possesses substantial biologic activity in vitro and in vivo. It is expressed in EFT cell lines and in primary tumors. Within these EFT cell lines, PDGF-C expression is dependent upon EWS/FLI activity. These results suggest that PDGF-C may be a significant mediator of EWS/FLI driven oncogenesis.
Insights
Aberrant transcription factors drive human cancers. This study identifies Platelet-Derived Growth Factor C (PDGF-C) as a key target of EWS/FLI-1 fusion proteins in Ewing Family Tumors (EFT), suggesting its role in oncogenesis.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Genetics
Background:
- Aberrant transcription factors are implicated in human malignancies by deregulating tumorigenic pathways.
- Ewing Family Tumors (EFT) characteristically involve EWS/ETS fusion proteins, particularly EWS/FLI-1.
- Identifying downstream targets of these fusion proteins has been challenging.
Purpose of the Study:
- To identify novel targets of EWS/FLI-1 transcriptional deregulation in EFT.
- To investigate the role of identified targets in EFT oncogenesis.
Main Methods:
- Utilized efficient retroviral systems to screen cDNA from EWS/FLI-1 transformed cells.
- Assessed gene expression and biological activity of potential targets in vitro and in vivo.
- Investigated the dependency of target gene expression on EWS/FLI-1 activity.
Main Results:
- Identified Platelet-Derived Growth Factor C (PDGF-C) as a direct transcriptional target of EWS/FLI-1.
- PDGF-C is expressed in EFT cell lines and primary tumors.
- PDGF-C expression in EFT cell lines is dependent on EWS/FLI-1 activity.
- PDGF-C exhibits significant in vitro and in vivo biologic activity.
Conclusions:
- PDGF-C is a novel, transcriptionally deregulated target of EWS/FLI-1 in EFT.
- PDGF-C may function as a significant mediator of EWS/FLI-1 driven oncogenesis in Ewing Family Tumors.
More Related Videos
09:58Mapping the Structure-Function Relationships of Disordered Oncogenic Transcription Factors Using Transcriptomic Analysis
Published on: June 27, 2020
06:54Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
Related Concept Videos
Mitogens and the Cell Cycle
Regulation of Angiogenesis and Blood Supply
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
TGF - β Signaling Pathway
Cadherins in Tissue Organization
Cell Sorting During Development
Cell sorting plays an...
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal